---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-062599"
form_type: "8-K"
ticker: "ALUR"
cik: "0001964979"
company_name: "ALLURION TECHNOLOGIES, INC."
filed_at: "2026-02-23T23:59:59+00:00"
generated_at: "2026-05-16T01:16:25.907588+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# FDA grants PMA approval for Allurion gastric balloon system for obesity

## Summary
- Allurion Smart Capsule approved for adults 22-65 with BMI 30-40 kg/m² after unsuccessful weight loss attempt.
- Balloon swallowed in 15-min office visit, no surgery/endoscopy/anesthesia; stays ~4 months, then passes naturally.
- AUDACITY pivotal trial data supported approval; over 200,000 patients treated outside US with 14% total body weight loss.
- Opens access to ~80 million US adults with obesity; alternative to GLP-1s and bariatric surgery.
- Company cited 65% GLP-1 discontinuation rate within first year and rapid weight regain as unmet need.

## SEC filing metadata
- accession: 0001193125-26-062599
- form_type: 8-K
- ticker: ALUR
- cik: 0001964979
- company_name: ALLURION TECHNOLOGIES, INC.
- filed_at: 2026-02-23T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1964979/000119312526062599/0001193125-26-062599-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1964979/000119312526062599/alur-20260223.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-062599
- JSON: https://secwatch.observer/filing/0001193125-26-062599.json
- Plain text: https://secwatch.observer/filing/0001193125-26-062599.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.